Health-care companies rose as the biotech sub-sector gathered momentum.
Moderna shares rose by more than 9%, and were headed for their largest monthly gain on record, due to enthusiasm about its cancer vaccine.
Jazz Pharmaceuticals shares rose after the Food and Drug Administration approved the drug maker's product candidate, Ziihera, to treat a form of stomach cancer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.